Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Jul 31, 2020 · 10-Q · 31 days after period end · 0001213900-20-019642
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$7.14M | -$5.32M | -$4.88M | -$5.61M |
| EPS Diluted | -$1.22 | -$0.56 | -$0.28 | -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Jul 31, 2020 · 31 d after period end
